본문 바로가기
KERD
논문KCI 등재

Human Umbilical Cord Blood CD34-Positive Cells as Predictors of the Incidence and Short-Term Outcome of Neonatal Hypoxic-Ischemic Encephalopathy: A Pilot Study

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background and Purpose Neonatal hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of neurological handicap in developing countries. Human umbilical cord blood (hUCB) CD34-positive (CD34+) stem cells exhibit the potential for neural repair. We tested the hypothesis that hUCB CD34+ stem cells and other cell types [leukocytes and nucleated red blood cells (NRBCs)] that are up-regulated during the acute stage of perinatal asphyxia (PA) could play a role in the early prediction of the occurrence, severity, and mortality of HIE. Methods This case-control pilot study investigated consecutive neonates exposed to PA. The hUCB CD34+ cell count in mononuclear layers was assayed using a flow cytometer. Twenty full-term neonates with PA and 25 healthy neonates were enrolled in the study. Results The absolute CD34+ cell count (p=0.02) and the relative CD34+ cell count (CD34+%) (p<0.001) in hUCB were higher in the HIE patients (n=20) than the healthy controls. The hUCB absolute CD34+ cell count (p=0.04), CD34+% (p<0.01), and Hobel risk scores (p=0.04) were higher in patients with moderate-to-severe HIE (n=9) than in those with mild HIE (n=11). The absolute CD34+ cell count was strongly correlated with CD34+% (p<0.001), Hobel risk score (p=0.04), total leukocyte count (TLC) (p<0.001), and NRBC count (p=0.01). CD34+% was correlated with TLC (p=0.02). Conclusions hUCB CD34+ cells can be used to predict the occurrence, severity, and mortality of neonatal HIE after PA.

Abstract

Background and Purpose Neonatal hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of neurological handicap in developing countries. Human umbilical cord blood (hUCB) CD34-positive (CD34+) stem cells exhibit the potential for neural repair. We tested the hypothesis that hUCB CD34+ stem cells and other cell types [leukocytes and nucleated red blood cells (NRBCs)] that are up-regulated during the acute stage of perinatal asphyxia (PA) could play a role in the early prediction of the occurrence, severity, and mortality of HIE. Methods This case-control pilot study investigated consecutive neonates exposed to PA. The hUCB CD34+ cell count in mononuclear layers was assayed using a flow cytometer. Twenty full-term neonates with PA and 25 healthy neonates were enrolled in the study. Results The absolute CD34+ cell count (p=0.02) and the relative CD34+ cell count (CD34+%) (p<0.001) in hUCB were higher in the HIE patients (n=20) than the healthy controls. The hUCB absolute CD34+ cell count (p=0.04), CD34+% (p<0.01), and Hobel risk scores (p=0.04) were higher in patients with moderate-to-severe HIE (n=9) than in those with mild HIE (n=11). The absolute CD34+ cell count was strongly correlated with CD34+% (p<0.001), Hobel risk score (p=0.04), total leukocyte count (TLC) (p<0.001), and NRBC count (p=0.01). CD34+% was correlated with TLC (p=0.02). Conclusions hUCB CD34+ cells can be used to predict the occurrence, severity, and mortality of neonatal HIE after PA.

참고문헌 (38)

  1. Lee AC, "Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990", Pediatr Res, 74(Suppl 1), pp.50~72 (2013)
  2. Itoo BA, "Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia", Neurosciences, 8, pp.113~119 (2003)
  3. Dixon BJ, "Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy", Int J Mol Sci, 16, pp.22368~22401 (2015)
  4. El Shimi MS, "Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings", J Matern Fetal Neonatal Med, 27, pp.1295~1300 (2014)
  5. Serpero LD, "Next generation biomarkers for brain injury", J Matern Fetal Neonatal Med, 26(Suppl 2), pp.44~49 (2013)
  6. Sahar M.A. Hassanein, "Safety and Efcacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial", Journal of Clinical Neurology, 12(1), pp.79~84 (2016), 대한신경과학회[DOI]
  7. Chalak LF, "Neurodevelopmental outcomes after hypothermia therapy in the era of Bayley-III", J Perinatol, 34, pp.629~633 (2014)
  8. Horn AR, "Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours", BMC Pediatr, 13, pp.52~ (2013)
  9. Hayakawa M, "Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan", Pediatr Int, 56, pp.215~221 (2014)
  10. Menticoglou SM, "How often do perinatal events at full term cause cerebral palsy?", J Obstet Gynaecol Can, 30, pp.396~403 (2008)
  11. Bhongir AV, "The urinary uric acid", creatinine ratio is an adjuvant marker for perinatal asphyxia, 2015, pp.2, 520~528
  12. Goel M, "Nucleated red blood cell in cord blood as a marker of perinatal asphyxia", J Clin Neonatol, 2, pp.179~182 (2013)
  13. Aly H, "Vascular endothelial growth factor in neonates with perinatal asphyxia", Brain Dev, 31, pp.600~604 (2009)
  14. Reali C, "Differentiation of human adult CD34+ stem cells into cells with a neural phenotype: role of astrocytes", Exp Neurol, 197, pp.399~406 (2006)
  15. Hobel CJ, "Prenatal and intrapartum highrisk screening. II. Risk factors reassessed", Am J Obstet Gynecol, 135, pp.1051~1056 (1979)
  16. Sarnat HB, "Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study", Arch Neurol, 33, pp.696~705 (1976)
  17. Thompson CM, "The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome", Acta Paediatr, 86, pp.757~761 (1997)
  18. Shankaran S, "Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy", N Engl J Med, 353, pp.1574~1584 (2005)
  19. Denning-Kendall PA, "Different behaviour of fresh and cultured CD34+ cells during immunomagnetic separation", Br J Haematol, 105, pp.780~785 (1999)
  20. van Laerhoven H, "Prognostic tests in term neonates with hypoxic-ischemic encephalopathy:a systematic review", Pediatrics, 131, pp.88~98 (2013)
  21. Surbek DV, "Umbilical cord blood collection for transplantation: which technique should be preferred?", Am J Obstet Gynecol, 183, pp.1587~1588 (2000)
  22. Axt R, "Nucleated red blood cells in cord blood of singleton term and post-term neonates", J Perinat Med, 27, pp.376~381 (1999)
  23. Mehrishi JN, "A novel method of CD34+ cell separation from umbilical cord blood", Transfusion, 53, pp.2675~2680 (2013)
  24. Sutherland DR, "The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering", J Hematother, 5, pp.213~226 (1996)
  25. Sidney LE, "Concise review: evidence for CD34 as a common marker for diverse progenitors", Stem Cells, 32, pp.1380~1389 (2014)
  26. Al-Deghaither SY, "Impact of maternal and neonatal factors on parameters of hematopoietic potential in umbilical cord blood", Saudi Med J, 36, pp.704~712 (2015)
  27. Kim JP, "A comparison of the kinetics of nucleated cells and CD34+ cells in neonatal peripheral blood and cord blood", Biol Blood Marrow Transplant, 13, pp.478~485 (2007)
  28. Liang CC, "The protective effect of human umbilical cord blood CD34+ cells and estradiol against focal cerebral ischemia in female ovariectomized rat: cerebral MR imaging and immunohistochemical study", PLoS One, 11, pp.e0147133~ (2016)
  29. Tsuji M, "Effects of intravenous administration of umbilical cord blood CD34(+)cells in a mouse model of neonatal stroke", Neuroscience, 263, pp.148~158 (2014)
  30. Boltze J, "Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo", Cell Transplant, 21, pp.723~737 (2012)
  31. Haase VH, "Regulation of erythropoiesis by hypoxia-inducible factors", Blood Rev, 27, pp.41~53 (2013)
  32. Elbuken G, "Evaluation of peripheral blood CD34+ cell count in the acute phase of traumatic brain injury and chest trauma", Brain Inj, 30, pp.179~183 (2016)
  33. Cotten CM, "Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy", J Pediatr, 164, pp.973~979 (2014)
  34. Aly H, "Viability and neural differentiation of mesenchymal stem cells derived from the umbilical cord following perinatal asphyxia", J Perinatol, 32, pp.671~676 (2012)
  35. Baburamani AA, "Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?", Front Physiol, 3, pp.424~ (2012)
  36. Fan J, "Role of the plasma membrane ROS-generating NADPH oxidase in CD34+ progenitor cells preservation by hypoxia", J Biotechnol, 130, pp.455~462 (2007)
  37. Dong W, "The enhanced ability of peripheral mononuclear cells differentiating into neural cells in term infants with good improvement suffering from severe hypoxic ischemic encephalopathy", Iran J Pediatr, 24, pp.435~440 (2014)
  38. McCarthy JM, "Umbilical cord nucleated red blood cell counts: normal values and the effect of labor", J Perinatol, 26, pp.89~92 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (22건)